Role of POU4F1 in a Novel Form of Ataxia

POU4F1 在新型共济失调中的作用

基本信息

批准号：
10741382
负责人：
Samuele Giuseppe Marro
金额：
$ 21.93万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-07-01 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10741382
关键词：
3-Dimensional ATAC-seq Abnormal coordination Address Adult Affect Afferent Neurons Alleles Animal Model Ataxia Atrophic Biology Brain Cell Maintenance Cell model Cells Cerebral cortex Childhood Chromatin Clinical Clinical assessments Computational Technique Data Development Developmental Delay Disorders Diagnosis Disease Epigenetic Process Equilibrium Exhibits Fibroblasts Functional disorder Gene Expression Gene Expression Profile Generations Genes Genetic Genetic Techniques Genetic Transcription Genotype Goals Health Care Costs Heterozygote Human Image Immunofluorescence Immunologic Impairment Individual Induced pluripotent stem cell derived neurons Inherited Spinocerebellar Degenerations Intellectual functioning disability Intellectual impairment Intention Tremor Learning Loss of Heterozygosity Mediating Microelectrodes Molecular Molecular Abnormality Molecular Genetics Morphology Movement Mus Muscle hypotonia Mutation Nervous System Neurodegenerative Disorders Neurologic Neuronal Differentiation Neurons Organoids POU Domain Pathogenicity Patients Peripheral Phenotype Play Procedures Production Property Records Reporting Role Sensory Specific qualifier value Speech Delay Synapses Syndrome Technology Testing Tissues Transcriptional Regulation Variant cell motility density differentiation protocol directed differentiation early onset exome sequencing experimental study fetal genome-wide human pluripotent stem cell improved in vitro Model induced pluripotent stem cell insight loss of function multidisciplinary mutant nervous system disorder neurogenesis neuron loss neuronal excitability neuronal survival novel overexpression patient registry programs stem cell model transcription factor transcriptome sequencing transcriptomics

3-Dimensional ATAC-seq Abnormal coordination Address Adult Affect Afferent Neurons Alleles Animal Model Ataxia Atrophic Biology Brain Cell Maintenance Cell model Cells Cerebral cortex Childhood Chromatin Clinical Clinical assessments Computational Technique Data Development Developmental Delay Disorders Diagnosis Disease Epigenetic Process Equilibrium Exhibits Fibroblasts Functional disorder Gene Expression Gene Expression Profile Generations Genes Genetic Genetic Techniques Genetic Transcription Genotype Goals Health Care Costs Heterozygote Human Image Immunofluorescence Immunologic Impairment Individual Induced pluripotent stem cell derived neurons Inherited Spinocerebellar Degenerations Intellectual functioning disability Intellectual impairment Intention Tremor Learning Loss of Heterozygosity Mediating Microelectrodes Molecular Molecular Abnormality Molecular Genetics Morphology Movement Mus Muscle hypotonia Mutation Nervous System Neurodegenerative Disorders Neurologic Neuronal Differentiation Neurons Organoids POU Domain Pathogenicity Patients Peripheral Phenotype Play Procedures Production Property Records Reporting Role Sensory Specific qualifier value Speech Delay Synapses Syndrome Technology Testing Tissues Transcriptional Regulation Variant cell motility density differentiation protocol directed differentiation early onset exome sequencing experimental study fetal genome-wide human pluripotent stem cell improved in vitro Model induced pluripotent stem cell insight loss of function multidisciplinary mutant nervous system disorder neurogenesis neuron loss neuronal excitability neuronal survival novel overexpression patient registry programs stem cell model transcription factor transcriptome sequencing transcriptomics

展开

项目摘要

PROJECT SUMMARY/ABSTRACT Heterozygous, pathogenic variants in POU4F1 were recently reported by our group to cause a novel ataxia syndrome (Webb et al., 2021). This neurological disorder is characterized by childhood onset ataxia, intention tremor, and hypotonia, and affected individuals have global developmental delay with mildly impaired intellectual development and speech delay or learning difficulties. POU4F1, also known as BRN3A, encodes a class IV POU-domain containing transcription factor expressed in the developing and adult brain. Little is known about the role POU4F1 plays in neurogenesis, neuronal differentiation, and neuronal survival in human neurons. Therefore, we propose to use iPSC to generate cellular models of the human brain to interrogate the consequences of POU4F1 haploinsufficiency. Our specific aims in this proposal are to 1) determine transcriptional signatures, epigenetic status, and functional abnormalities resulting from POU4F1 haploinsufficiency in iPSC – derived neurons; 2) assess the impact of POU4F1 haploinsufficiency in a iPSC model of the developing brain using cortical organoids; and 3) create a patient registry for POU4F1-related ataxia and better define the clinical features of this newly identified disorder. Taken together, these studies will uncover the pathophysiology, disease mechanism, and clinical spectrum of disease of POU4F1-related ataxia and address fundamental questions of human neurodevelopmental biology.

项目摘要/摘要我们的小组最近报道了POU4F1中的杂合子，致病性变异，以引起一种新型的共济失调综合征（Webb等，2021）。这种神经系统疾病的特征是共济发作，意图震颤和低位症和受影响的个体有全球发育延迟，轻度受损智力发展和语音延迟或学习困难。 POU4F1，也称为BRN3A，编码A 在发育和成人大脑中表达的含有转录因子的IV类POU域。几乎没有关于POU4F1在人类中的神经发生，神经元分化和神经元存活中的作用已知神经元。因此，我们建议使用IPSC生成人脑的细胞模型来询问 POU4F1单倍弥补的后果。我们在此提案中的具体目的是1）确定 POU4F1产生的转录特征，表观遗传状态和功能异常 IPSC中的单倍不足 - 衍生的神经元； 2）评估POU4F1单倍性对IPSC的影响使用皮质器官的发育大脑模型； 3）创建与POU4F1相关的患者注册表共济失调并更好地定义了这种新确定的疾病的临床特征。两者一起，这些研究将揭示与POU4F1共济失调疾病的病理生理学，疾病机制和临床光谱并解决人类神经发育生物学的基本问题。